🔎 Trials Near Me

Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Illinois › Chicago

Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Chicago, IL

Masomo 18 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Chicago na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

InaajiriHatua 2
  • Northwestern University - Feinberg School of Medicine, Chicago
  • Rush University Medical Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

InaajiriHatua 2
  • Northwestern University, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06649812

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

InaajiriHatua 1
  • The University of Chicago Medical Center (UCMC), Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

InaajiriHatua 1
  • University of Chicago Comprehensive Cancer Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT05272384

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

InaajiriHatua 1/2
  • University of Chicago, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07284433

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

InaajiriHatua 1/2
  • University of Chicago Medical Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04104776

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

InaajiriUtafiti wa uchunguzi
  • Robert H Lurie Cancer Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

InaajiriHatua 3
  • Northwestern, Chicago
  • University of Chicago, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

InaajiriHatua 2
  • Robert H Lurie Cancer Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

InaajiriHatua 1
  • University of Illinois at Chicago, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Jul 2026 · NCT05077527

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

InaajiriHatua 1
  • Northwestern University, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT06015880

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

InaajiriHatua 1
  • Northwestern University, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT05131022

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

InaajiriHatua 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Umri 12 hadi 95 · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

InaajiriHatua 1
  • The University of Chicago Medical Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Mac 2026 · NCT04830137

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

InaajiriHatua 2
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Feb 2026 · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

InaajiriHatua 2
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Okt 2025 · NCT05890352

A Study of NX-1607 in Adults With Advanced Malignancies

InaajiriHatua 1
  • University of Chicago, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2025 · NCT05107674

Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine

Masomo mengine katika Chicago

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.